Exhibit 99.2 I AM CANNABIS IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of March 31,2023 (Unaudited) | | Page | | --- | --- | | Interim Condensed Consolidated Statements of Financial Position | 2 - 3 | | Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income | 4 - 5 | | Interim Condensed Consolidated Statements of Changes in Equity | 6 | | Interim Condensed Consolidated Statements of Cash Flows | 7 - 8 | | Notes to Interim Condensed Consolidate ...

WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________________ to ____________________ OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ SHELL COMPANY REPORT P ...

IM Cannabis Corp. (NASDAQ:IMCC) Q4 2022 Earnings Conference Call March 29, 2023 9:00 AM ET Company Participants Maya Lustig - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Shai Shemesh - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Scott Fortune - Roth Capital Partners Operator Good day, and welcome to IM Cannabis' Fourth Quarter and Full Year 2022 Earnings Conference Call. Today's conference call is being recorded. At this tim ...

Exhibit 99.1 IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively managing costs and margins TORONTO, and GLIL YAM, Israel, March 28, 2023 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an internationa ...

IM Cannabis Corp. (NASDAQ:IMCC) Q3 2022 Earnings Conference Call November 14, 2022 9:00 AM ET Company Participants Oren Shuster - Chief Executive Officer Shai Shemesh - Chief Financial Officer Maya Lustig - Investor Relations Conference Call Participants Aaron Grey - Alliance Global Partners Scott Fortune - Roth Capital Partners Operator Good day and welcome to IM CannabisÂ' Third Quarter 2022 Earnings Conference Call. TodayÂ's conference is being recorded. At this time, I would like to turn the conference ...

Exhibit 99.2 IM CANNABIS CORP. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2022 UNAUDITED IM CANNABIS CORP. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2022 CANADIAN DOLLARS IN THOUSANDS UNAUDITED INDEX | | Page | | --- | --- | | Interim Condensed Consolidated Statements of Financial Position | F - 2 – F - 3 | | Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income | F - 4 – ...

CANADIAN DOLLARS IN THOUSANDS (Unaudited) Exhibit 99.2 IM CANNABIS CORP. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2022 INDEX | Page | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Interim Condensed Consolidated Statements of Financial Position | F - 3 - F - 4 | | | | | | | | | | | Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income | F - 5 - F - 6 | | | | | | | | | | | Interim Co ...

IM Cannabis Corp. (NASDAQ:IMCC) Q2 2022 Earnings Conference Call August 15, 2022 9:00 AM ET Company Participants Maya Lustig - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Shai Shemesh - Chief Financial Officer Conference Call Participants Aaron Grey - AGP Adam Altberg - BMO Operator Good day and welcome to IM Cannabis Second Quarter 2022 Earnings Conference Call. TodayÂ's conference call is being recorded. At this time, I would like to turn the conference over to Maya Lust ...

Financial Data and Key Metrics Changes - Revenues increased 169% year-over-year and 18% sequentially to $23.6 million in Q1 2022, compared to $8.8 million in Q1 2021 [7][20] - Gross profit before fair value adjustments rose 37% to $6.4 million in Q1 2022 from $4.6 million in Q1 2021 [21] - Net loss was $10.7 million in Q1 2022, compared to a net income of $4.7 million in Q1 2021, with basic loss per share at $0.14 [21][22] Business Line Data and Key Metrics Changes - The company is transitioning its supply source towards a third supply model leveraging Canadian yield, which is expected to enhance margin expansion [6][10] - The WAGNERS brand launched in Israel has received positive consumer feedback, contributing to the company's growth strategy [13][41] Market Data and Key Metrics Changes - In Canada, the company’s brands, WAGNERS and Highland Grow, are gaining market share, particularly in Ontario, Canada’s largest cannabis market [14] - The German market is being positioned for growth, with the company establishing a positive reputation and planning to launch the WAGNERS brand there [16][17] Company Strategy and Development Direction - The company aims to capture market share while integrating its global model to become a leading consumer packaged goods company in the cannabis industry [26] - Significant investments are being made in Germany to establish a foundation for future growth in the evolving cannabis market [17][18] Management's Comments on Operating Environment and Future Outlook - Management expects Q2 2022 revenues to accelerate year-over-year and approach positive adjusted EBITDA by the end of the quarter [23] - The company acknowledges a slowdown in the Israeli market but remains optimistic about overall growth [33] Other Important Information - The company does not foresee significant capital expenditures in the coming year as it focuses on operational improvements and synergies [24] - Cash and cash equivalents totaled $10.3 million at March 31, 2022, down from $13.9 million at December 31, 2021 [22] Q&A Session Summary Question: Clarification on Q2 profitability and EBITDA guidance - Management believes that adjusted EBITDA will be positive from June onwards, but cannot confirm if the entire quarter will be profitable [29] Question: Outlook on the Israeli market and industry sales - Management noted a slower growth rate in the Israeli market but emphasized that the market is still growing [33] Question: Commentary on Canadian market sales trends - Management confirmed ongoing market share capture in Canada and plans to enter the Quebec market, which is significant [35] Question: Allocation priorities between Canadian and international markets - The company is optimizing product allocation based on market margins and is in the early stages of this process [39] Question: Revenue contribution from Germany and timing for product exports - Revenue from Germany was $600,000 for the quarter, with expectations for product imports to begin in Q4 2022 [45]

IM Cannabis Corp. (NASDAQ:IMCC) Q4 2021 Earnings Conference Call March 31, 2022 9:00 AM ET Company Participants Oren Shuster – Chief Executive Officer Shai Shemesh – Chief Financial Officer Maya Lustig – Investor Relations Conference Call Participants Aaron Grey – Alliance Global Partners Scott Fortune – Roth Capital Partners Adam Altberg – BMO Operator Good day, and welcome to IM Cannabis Fourth Quarter and Fiscal Year 2021 Earnings Conference Call. Today's conference call is being recorded. At this time, ...